COVID Drug May Also Ease Symptoms of Long COVID

An antiviral drug approved for high-risk COVID patients may also benefit those with long COVID, according to the findings of a small case series that need to be confirmed with future rigorous studies.

Your Mental Health May Impact Your Chances of Breakthrough COVID

A new UCSF-led study showed that people who are vaccinated against COVID-19, and have a history of certain psychiatric conditions, have a heightened risk of infection – a finding that may be related to impaired immune response.

USCF Deploys Innovative Data System to Integrate Research and Care

UCSF, in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA), has developed the OneSource system to seamlessly integrate clinical care and research data.

UCSF Deploys Innovative Data System to Integrate Research and Care

UCSF, in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA), has developed the OneSource system to seamlessly integrate clinical care and research data.

Homeless Deaths Doubled in San Francisco During the Pandemic’s First Year, Mostly from Drug Overdoses

More than twice as many people experiencing homelessness in San Francisco died during the first year of the COVID-19 pandemic compared to previous years, with the leading cause of death being drug overdose. No deaths were attributed to the virus itself.

Cerebrospinal Fluid Offers Clues to Post-COVID ‘Brain Fog’

Many patients with COVID-19 develop brain fog and other cognitive symptoms months later. Their cerebrospinal fluid may hold clues to why this is happening.

Human Proteins Behind COVID-19 Infection Revealed by Innovative CRISPR Technology

In the quest for new treatments for COVID-19, a team led by UCSF researchers identified a new potential drug target that may prevent infection of human cells by SARS-CoV-2.

Alpha Coronavirus Variant Evolved to Evade Immune System

A new study led by scientists at UCSF's Quantitative Biosciences Institute and University College London found that the Alpha variant of SARS-CoV-2 ramped up production of a protein that it uses to stifle infected cells’ immune-stimulating signals, helping it evade immune detection and accelerate...

As Omicron Surges, UCSF Experts Answer Questions About the COVID-19 Variant

There is some information that is known about the variant and other information that sti

COVID Patients on SSRI Antidepressants Are Less Likely to Die, UCSF-Stanford Study Finds

A UCSF and Stanford study of electronic health records linked SSRIs, the most widely prescribed antidepressants, to survival for COVID-19 patients.